An activator of the cAMP/PKA/CREB pathway promotes osteogenesis from human mesenchymal stem cells

Journal of Cellular Physiology

Volumn 228, Issue 3, 2013, Pages 617-626

  Kim, Jung Min ^a,b   Choi, Jin Seok ^c   Kim, Yun Hee ^d   Jin, Seong Hui ^b   Lim, Seyoung ^a   Jang, Hyun Jun ^a,b   Kim, Kyong Tai ^b   Ryu, Sung Ho ^b   Suh, Pann Ghill ^a  

^a Ulsan National Institute of Science and Technology   (South Korea)

^b Pohang University of Science and Technology (POSTECH)   (South Korea)

^c Central Research Institute   (South Korea)

^d National Cancer Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; CW 008; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; LEPTIN; PYRAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN SECRETION;

ADULT STEM CELLS; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; LEPTIN; MESENCHYMAL STROMAL CELLS; MICE; OSTEOGENESIS; OSTEOPOROSIS; PYRAZOLES; PYRIDINES; SIGNAL TRANSDUCTION;

MUS;

EID: 84870449303     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24171     Document Type: Article

References (43)

1. Alexander JM, Bab I, Fish S, Muller R, Uchiyama T, Gronowicz G, Nahounou M, Zhao Q, White DW, Chorev M, Gazit D, Rosenblatt M. 2001. Human parathyroid hormone 1-34 reverses bone loss in ovariectomized mice. J Bone Miner Res 16:1665-1673.
2. Altarejos JY, Montminy M. 2011. CREB and the CRTC co-activators: Sensors for hormonal and metabolic signals. Nat Rev Mol Cell Biol 12:141-151.
3. Baron R, Ferrari S, Russell RG. 2011. Denosumab and bisphosphonates: Different mechanisms of action and effects. Bone 48:677-692.
4. Bianco P, Riminucci M, Gronthos S, Robey PG. 2001. Bone marrow stromal stem cells: Nature, biology, and potential applications. Stem Cells 19:180-192.
5. Bidwell P, Joh K, Leaver HA, Rizzo MT. 2010. Prostaglandin E2 activates cAMP response element-binding protein in glioma cells via a signaling pathway involving PKA-dependent inhibition of ERK. Prostaglandins Other Lipid Mediat 91:18-29.
6. Cammisotto PG, Bukowiecki LJ. 2002. Mechanisms of leptin secretion from white adipocytes. Am J Physiol Cell Physiol 283:C244-C250.
7. Canalis E, Giustina A, Bilezikian JP. 2007. Mechanisms of anabolic therapies for osteoporosis. N Engl J Med 357:905-916.
8. Daniel PB, Walker WH, Habener JF. 1998. Cyclic AMP signaling and gene regulation. Annu Rev Nutr 18:353-383.
9. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G. 2000. Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass. Cell 100:197-207.
10. Elefteriou F, Takeda S, Ebihara K, Magre J, Patano N, Kim CA, Ogawa Y, Liu X, Ware SM, Craigen WJ, Robert JJ, Vinson C, Nakao K, Capeau J, Karsenty G. 2004. Serum leptin level is a regulator of bone mass. Proc Natl Acad Sci USA 101:3258-3263.
11. Feng X, McDonald JM. 2011. Disorders of bone remodeling. Annu Rev Pathol 6:121-145.
12. Goltzman D. 2002. Discoveries, drugs, and skeletal disorders. Nat Rev Drug Discov 1:784-796.
13. Hartikka H, Makitie O, Mannikko M, Doria AS, Daneman A, Cole WG, Ala-Kokko L, Sochett EB. 2005. Heterozygous mutations in the LDL receptor-related protein 5 (LRP5) gene are associated with primary osteoporosis in children. J Bone Miner Res 20:783-789.
14. Hsu HT, Chang YC, Chiu YN, Liu CL, Chang KJ, Guo IC. 2006. Leptin interferes with adrenocorticotropin/3′, 5′-cyclic adenosine monophosphate (cAMP) signaling, possibly through a Janus kinase 2-phosphatidylinositol 3-kinase/Akt-phosphodiesterase 3-cAMP pathway, to down-regulate cholesterol side-chain cleavage cytochrome P450 enzyme in human adrenocortical NCI-H295 cell line. J Clin Endocrinol Metab 91:2761-2769.
15. Huang WC, Xie Z, Konaka H, Sodek J, Zhau HE, Chung LW. 2005. Human osteocalcin and bone sialoprotein mediating osteomimicry of prostate cancer cells: Role of cAMP-dependent protein kinase A signaling pathway. Cancer Res 65:2303-2313.
16. Ionescu AM, Drissi H, Schwarz EM, Kato M, Puzas JE, McCance DJ, Rosier RN, Zuscik MJ, O'Keefe RJ. 2004. CREB Cooperates with BMP-stimulated Smad signaling to enhance transcription of the Smad6 promoter. J Cell Physiol 198:428-440.
17. Isogai Y, Akatsu T, Ishizuya T, Yamaguchi A, Hori M, Takahashi N, Suda T. 1996. Parathyroid hormone regulates osteoblast differentiation positively or negatively depending on the differentiation stages. J Bone Miner Res 11:1384-1393.
18. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP. 1997. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 64:295-312.
19. Jaiswal RK, Jaiswal N, Bruder SP, Mbalaviele G, Marshak DR, Pittenger MF. 2000. Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. J Biol Chem 275:9645-9652.
20. Jerome CP, Peterson PE. 2001. Nonhuman primate models in skeletal research. Bone 29:1-6.
21. Jilka RL. 2007. Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. Bone 40:1434-1446.
22. Khosla S, Westendorf JJ, Oursler MJ. 2008. Building bone to reverse osteoporosis and repair fractures. J Clin Invest 118:421-428.
23. Kurabayashi M, Dutta S, Jeyaseelan R, Kedes L. 1995. Doxorubicin-induced Id2A gene transcription is targeted at an activating transcription factor/cyclic AMP response element motif through novel mechanisms involving protein kinases distinct from protein kinase C and protein kinase A. Mol Cell Biol 15:6386-6397.
24. Lane NE. 2006. Therapy insight: Osteoporosis and osteonecrosis in systemic lupus erythematosus. Nat Clin Pract Rheumatol 2:562-569.
25. Matsuo N, Tanaka S, Gordon MK, Koch M, Yoshioka H, Ramirez F. 2006. CREB-AP1 protein complexes regulate transcription of the collagen XXIV gene (Col24a1) in osteoblasts. J Biol Chem 281:5445-5452.
26. Ofek O, Karsak M, Leclerc N, Fogel M, Frenkel B, Wright K, Tam J, Attar-Namdar M, Kram V, Shohami E, Mechoulam R, Zimmer A, Bab I. 2006. Peripheral cannabinoid receptor, CB2, regulates bone mass. Proc Natl Acad Sci USA 103:696-701.
27. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
28. Rachner TD, Khosla S, Hofbauer LC. 2011. Osteoporosis: Now and the future. Lancet 377:1276-1287.
29. Reseland JE, Syversen U, Bakke I, Qvigstad G, Eide LG, Hjertner O, Gordeladze JO, Drevon CA. 2001. Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. J Bone Miner Res 16:1426-1433.
30. Sahu A. 2004. Minireview: A hypothalamic role in energy balance with special emphasis on leptin. Endocrinology 145:2613-2620.
31. Sands WA, Palmer TM. 2008. Regulating gene transcription in response to cyclic AMP elevation. Cell Signal 20:460-466.
32. Siddappa R, Martens A, Doorn J, Leusink A, Olivo C, Licht R, van Rijn L, Gaspar C, Fodde R, Janssen F, van Blitterswijk C, de Boer J. 2008. cAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivo. Proc Natl Acad Sci USA 105:7281-7286.
33. Smoum R, Bar A, Tan B, Milman G, Attar-Namdar M, Ofek O, Stuart JM, Bajayo A, Tam J, Kram V, O'Dell D, Walker MJ, Bradshaw HB, Bab I, Mechoulam R. 2010. Oleoyl serine, an endogenous N-acyl amide, modulates bone remodeling and mass. Proc Natl Acad Sci USA 107:17710-17715.
34. Strewler GJ, Stern PH, Jacobs JW, Eveloff J, Klein RF, Leung SC, Rosenblatt M, Nissenson RA. 1987. Parathyroid hormonelike protein from human renal carcinoma cells: Structural and functional homology with parathyroid hormone. J Clin Invest 80:1803-1807.
35. Szkudelski T. 2007. Intracellular mediators in regulation of leptin secretion from adipocytes. Physiol Res 56:503-512.
36. Szkudelski T, Nowicka E, Szkudelska K. 2005. Leptin secretion and protein kinase A activity. Physiol Res 54:79-85.
37. Thomas T, Gori F, Khosla S, Jensen MD, Burguera B, Riggs BL. 1999. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 140:1630-1638.
38. Tintut Y, Parhami F, Bostrom K, Jackson SM, Demer LL. 1998. cAMP stimulates osteoblast-like differentiation of calcifying vascular cells: Potential signaling pathway for vascular calcification. J Biol Chem 273:7547-7553.
39. Yamane H, Sakai A, Mori T, Tanaka S, Moridera K, Nakamura T. 2009. The anabolic action of intermittent PTH in combination with cathepsin K inhibitor or alendronate differs depending on the remodeling status in bone in ovariectomized mice. Bone 44:1055-1062.
40. Yang X, Matsuda K, Bialek P, Jacquot S, Masuoka HC, Schinke T, Li L, Brancorsini S, Sassone-Corsi P, Townes TM, Hanauer A, Karsenty G. 2004. ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry syndrome. Cell 117:387-398.
41. Yasothan U, Kar S. 2008. Osteoporosis: Overview and pipeline. Nat Rev Drug Discov 7:725-726.
42. Zaidi M. 2007. Skeletal remodeling in health and disease. Nat Med 13:791-801.
43. Zhang Y, Wang Y, Li X, Zhang J, Mao J, Li Z, Zheng J, Li L, Harris S, Wu D. 2004. The LRP5 high-bone-mass G171V mutation disrupts LRP5 interaction with Mesd. Mol Cell Biol 24:4677-4684.